Morning news brief
President Biden meets with House Speaker McCarthy to discuss the debt ceiling, thousands are expected to attend Tyre Nichols' funeral in Memphis, the Fed is expected to raise interest rates again.
Business
Boeing delivers its final 747 jet, ending a run of more than 50 years
The airline manufacturer delivered its last 747 jumbo jet on Tuesday after a production run of more than five decades. Current and former workers said farewell to the "Queen of the Skies" with pride.
New York's AG is suing for fraud after some nursing home owners took large profits
After the nursing home where Leann Sample worked was bought by private investors, it started falling apart. Literally. But the owners of the facility were making huge profits.
A look at how inflation may be starting to ease
There has been a string of negative news about the economy this month — but nonetheless, stock and bond markets are headed for big gains in January. What gives?
How the pandemic changed the rules of personal finance
A new book says the Great Resignation was really the Great Reshuffle.
Big oil saw big profits in 2022
Exxon reported more than $55 billion in profits for 2022, a record for the U.S. oil industry. Sky-high profits for oil have prompted windfall taxes in Europe and political pressure in the U.S.
Nursing home owners drained cash while residents deteriorated, state filings suggest
As the U.S. government debates whether to require higher staffing levels at nursing homes, financial records show some owners routinely push profits to sister companies while residents are neglected.
Trump sues Bob Woodward for releasing audio of their interviews without permission
The former president has made good on his threat to sue the Washington Post reporter over his use of interview recordings. The lawsuit seeks nearly $50 million in damages.
The Fed kicks off a 2-day meeting with another interest rate hike expected
NPR's Steve Inskeep talks to Ken Kuttner, economics professor at Williams College, about the Federal Reserve's next expected interest rate hike. It would mark the eighth increase since March of 2022.
AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.